Literature DB >> 21046393

Prevalence of a streptococcal inhibitor of a complement-mediated cell lysis-like gene (sicG) in Streptococcus dysgalactiae subsp. equisimilis.

Masaaki Minami1, Mariko Ichikawa, Hideyuki Matsui, Nanako Hata, Naoki Wakiyama, Masakado Matsumoto, Michio Ohta, Tadao Hasegawa.   

Abstract

Streptococcus dysgalactiae subsp. equisimilis isolates (n = 110) were analyzed by PCR to determine whether the gene encoding SICG, a homolog of Streptococcus pyogenes SIC, was present. Nineteen strains (17%) had this gene of which 11 (55%) were isolated from patients with invasive disease. All 19 strains possessed group G carbohydrate. Molecular characterization of emm type revealed that the majority of emm sequences were stG643 and stG2078. Only the N-terminal sequence of SICG was similar to that of SIC in S. pyogenes. Although we found no significant relationship between pathogenic severity and sicG possession, further investigation into the mechanism of SICG may elucidate the virulence in S. dysgalactiae subsp. equisimilis infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21046393     DOI: 10.1007/s00284-010-9798-8

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  12 in total

1.  Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves.

Authors:  N P Hoe; K Nakashima; S Lukomski; D Grigsby; M Liu; P Kordari; S J Dou; X Pan; J Vuopio-Varkila; S Salmelinna; A McGeer; D E Low; B Schwartz; A Schuchat; S Naidich; D De Lorenzo; Y X Fu; J M Musser
Journal:  Nat Med       Date:  1999-08       Impact factor: 53.440

2.  drs (Distantly related sic) gene polymorphisms among emm12-type Streptococcus pyogenes isolates.

Authors:  Claudia M Brandt; Gerhard Haase; Barbara Spellerberg; Regina Holland; Rudolf Lütticken
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases.

Authors:  Mark R Davies; David J McMillan; Robert G Beiko; Vanessa Barroso; Robert Geffers; Kadaba S Sriprakash; Gursharan S Chhatwal
Journal:  Clin Infect Dis       Date:  2007-04-19       Impact factor: 9.079

4.  Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B.

Authors:  Laura N Broyles; Chris Van Beneden; Bernard Beall; Richard Facklam; P Lynn Shewmaker; Paul Malpiedi; Pamala Daily; Arthur Reingold; Monica M Farley
Journal:  Clin Infect Dis       Date:  2009-03-15       Impact factor: 9.079

5.  Streptococcus pyogenes strains containing emm12 and emm55 possess a novel gene coding for distantly related SIC protein.

Authors:  J Hartas; K S Sriprakash
Journal:  Microb Pathog       Date:  1999-01       Impact factor: 3.738

6.  Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States.

Authors:  Yusra Ahmad; Robert E Gertz; Zhongya Li; Varja Sakota; Laura N Broyles; Chris Van Beneden; Richard Facklam; P Lynn Shewmaker; Arthur Reingold; Monica M Farley; Bernard W Beall
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

7.  Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function.

Authors:  P Akesson; A G Sjöholm; L Björck
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

8.  Clinical aspects of invasive infections with Streptococcus dysgalactiae ssp. equisimilis in Japan: differences with respect to Streptococcus pyogenes and Streptococcus agalactiae infections.

Authors:  T Takahashi; K Sunaoshi; K Sunakawa; S Fujishima; H Watanabe; K Ubukata
Journal:  Clin Microbiol Infect       Date:  2009-09-02       Impact factor: 8.067

9.  Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome.

Authors:  Shinnosuke Hashikawa; Yoshitsugu Iinuma; Manabu Furushita; Teruko Ohkura; Toshi Nada; Keizo Torii; Tadao Hasegawa; Michio Ohta
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

10.  Establishment and characterisation of human carcinoembryonic antigen transgenic mice.

Authors:  T Hasegawa; K Isobe; Y Tsuchiya; S Oikawa; H Nakazato; H Ikezawa; I Nakashima; K Shimokata
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

View more
  5 in total

1.  Sequence diversity of sicG among group C and G Streptococcus dysgalactiae subspecies equisimilis isolates associated with human infections in western Norway.

Authors:  O Oppegaard; H Mylvaganam; S Skrede; N Langeland; B R Kittang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-10       Impact factor: 3.267

2.  Seropositivity for Antibodies to DRS-G, a Virulence Factor from Streptococcus dysgalactiae subsp. equisimilis, Is an Independent Risk Factor for Poststreptococcus Glomerulonephritis and Chronic Kidney Disease in Mumbai, India.

Authors:  Gouri P Hule; Mohan G Karmarkar; Ainslie Cameron; Niwrutti Hase; Uday Khopkar; Preeti R Mehta; Celia L McNeilly; David McMillan; Kadaba S Sriprakash
Journal:  Clin Vaccine Immunol       Date:  2015-06-17

3.  DrsG from Streptococcus dysgalactiae subsp. equisimilis inhibits the antimicrobial peptide LL-37.

Authors:  Danielle Smyth; Ainslie Cameron; Mark R Davies; Celia McNeilly; Louise Hafner; Kadaba S Sriprakash; David J McMillan
Journal:  Infect Immun       Date:  2014-03-24       Impact factor: 3.441

4.  Horizontal gene transfer and recombination in Streptococcus dysgalactiae subsp. equisimilis.

Authors:  Celia L McNeilly; David J McMillan
Journal:  Front Microbiol       Date:  2014-12-15       Impact factor: 5.640

5.  Prevalence of Complement-Mediated Cell Lysis-like Gene (sicG) in Streptococcus dysgalactiae subsp. equisimilis Isolates From Japan (2014-2016).

Authors:  Takashi Takahashi; Tomohiro Fujita; Akiyoshi Shibayama; Yuzo Tsuyuki; Haruno Yoshida
Journal:  Ann Lab Med       Date:  2017-07       Impact factor: 3.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.